Cigna (CI) Stock
Major US health insurer combining insurance with pharmacy services. Here's the price, business snapshot, and what's worth knowing about Cigna in October 2026.
Cigna Corporation (CI) is a large, US‑based health‑care and services company combining traditional health insurance with pharmacy and care‑management services through its Evernorth business. Its revenue mix includes employer and individual medical plans, Medicare products, and pharmacy benefit management and care solutions. Investors typically watch member trends, medical cost inflation, price negotiations with providers and drug‑pricing dynamics — all of which can move margins and earnings. Cigna’s business is sensitive to regulation, reimbursement changes and economic cycles that affect employer-sponsored coverage. With a market capitalisation of about $82.08 billion, it’s considered a major industry participant, but not immune to competition from insurers, PBMs and new entrants. This summary is general educational information, not personalised financial advice. Investors should consider their own circumstances, risk tolerance and seek regulated advice if needed; values can fall as well as rise and past performance is not a guide to future results.
Why It’s Moving
Cigna Sets Q3 Earnings Date and Launches AI-Driven Health Sense Platform
- Earnings Release Scheduled: The company will report its third quarter 2026 financial results on Thursday, November 5, 2026, followed by a conference call the same day.
- New Product Launch: Cigna Healthcare introduced 'Health Sense,' a platform designed to connect guidance, benefits, and clinical support to help customers make informed decisions and act sooner.
- Cost Efficiency Target: The new Health Sense initiative is projected to reduce inefficient health care spending by 10% by 2030, aiming to improve affordability for both employers and customers.
Cigna Sets Q3 Earnings Date and Launches AI-Driven Health Sense Platform
- Earnings Release Scheduled: The company will report its third quarter 2026 financial results on Thursday, November 5, 2026, followed by a conference call the same day.
- New Product Launch: Cigna Healthcare introduced 'Health Sense,' a platform designed to connect guidance, benefits, and clinical support to help customers make informed decisions and act sooner.
- Cost Efficiency Target: The new Health Sense initiative is projected to reduce inefficient health care spending by 10% by 2030, aiming to improve affordability for both employers and customers.
Sixth Month Growth Performance
When is the next earnings date for Cigna Corp (CI)?
The next confirmed earnings date for CI is November 5, 2026. This report will cover the company's third-quarter financial results. Investors should note that the specific time of day for this release has not yet been determined.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Cigna's stock with a target price of $358.25, indicating strong potential growth.
Financial Health
Cigna Corp is performing well with solid revenue and cash flow, indicating good financial stability.
Dividend
Cigna's dividend yield of 2.19% is reasonable for investors seeking some income. If you invested $1000 you would be paid $21.90 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Pharmacy & care growth
Evernorth’s pharmacy and care‑management services can drive revenue diversification and margin enhancement, though execution and pricing pressure matter.
US‑focused footprint
Cigna’s operations are primarily US‑centred, so domestic regulation and employer benefits trends heavily influence results; global shocks can still have indirect effects.
Regulation and margins
Policy shifts, reimbursement rates and drug pricing reforms can materially affect profitability — investors should factor regulatory risk into valuations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
